Physician profile
Luke E Boone
NPI 1154749802
$5,846.68
in general payments reported to CMS, 2019-2025
14 companies · $611 in 2025
The $611 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.00 · 2020: $559 · 2021: $1,915 · 2022: $1,952 · 2023: $293 · 2024: $495 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,399.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $2,400.00 | 2021-2022 | |
| Stryker Corporation | $971.86 | 2020-2022 | |
| Mentor Worldwide LLC | $718.18 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $400.59 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Tela Bio, INC. | $303.00 | 2022-2024 | Ovitex 2s |
| Sientra, INC. | $267.21 | 2022 | |
| Motiva USA, LLC | $224.65 | 2025 | |
| Allergan, INC. | $140.58 | 2022 | |
| Axogen | $117.71 | 2021 | |
| Integra Lifesciences Corporation | $99.25 | 2023 | Durasorb Monofilament Mesh |
| Davol INC. | $96.01 | 2023 | Phasix Mesh |
| Lifenet Health | $71.18 | 2025 | Theragenesis Wound Matrix |
| Ethicon US, LLC | $20.00 | 2019 | |
| Revance Therapeutics, INC. | $16.46 | 2025 | Daxxify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Boone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.